speb/financial-data huggingface dataset:
Financial ratios for SCANA.OL — annual report dated 2024-12-31
Total revenue: 152912621.3592233
Gross profit: 71774051.19152692
Operating income: 9373345.10150044
Net income: 7352162.40070609
Capital expenditures: 2215357.4580759048
Operating cash flow: 12930273.60988526
Depreciation & amortization: 9611650.485436894
Net tangible assets: 24819064.430714916
Owner earnings: 14748455.428067079
Return on net tangible assets (%): 59.42389758179232
Capex to operating income (%): 23.634651600753298
Buffett classification: The Great
Stock price: 0.25308641975308643
P/E ratio: 15.899632261764706
Shares outstanding: 461884437
Book value: 58614298.32303618
P/B ratio: 1.9943372495181455
Market cap (USD): 116896678.5
Debt to equity: 0.7265472067459722
Current ratio: 1.1188345077128166
Quick ratio: 0.9295372310036184
Effective tax rate (%): 24.203821656050955
Interest coverage ratio: 2.8548387096774195
COGS to revenue (%): 53.06204906204906
SG&A to revenue (%): 4.883116883116883
Free cash flow (dilution-adjusted): 5781112.091791703
Buyback yield (%): 0
Inventory turnover: 9.248490945674044
Receivables turnover: 5.288461538461539
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 10.151022748996368
FCF margin (%): 3.7806637806637804
Revenue growth (%): -3.0667858872349867
Rule of 40 score: 0.7138778934287937
Financial ratios for SCANA.OL — quarterly report dated 2025-03-31
Total revenue: 35104961.83206107
Gross profit: 20009541.984732825
Operating income: -3406488.5496183205
Net income: -2738549.6183206104
Capital expenditures: 1727099.2366412212
Operating cash flow: -2175572.5190839693
Depreciation & amortization: 2786259.5419847327
Net tangible assets: 24208015.26717557
Owner earnings: -1679389.3129770989
Return on net tangible assets (%): -6.937327552227039
Buffett classification: The Gruesome
Stock price: 0.2194656488549618
Shares outstanding: 461884437
Book value: 60629770.9923664
P/B ratio: 1.6719140779036827
Market cap (USD): 101367767.66221373
Debt to equity: 0.871262197041234
Current ratio: 1.0276254316473694
Quick ratio: 0.7834653666463538
COGS to revenue (%): 43.00081543897799
Free cash flow (dilution-adjusted): -3912213.740458015
Buyback yield (%): 0
Inventory turnover: 1.3161397670549084
Receivables turnover: 2.0169956140350878
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -3.494176372712147
FCF margin (%): -11.144332699103018
Rule of 40 score: -11.144332699103018
Financial ratios for SCANA.OL — quarterly report dated 2025-06-30
Total revenue: 39304865.93843098
Gross profit: 21767626.61370407
Operating income: -2234359.483614697
Net income: -2492552.1350546177
Capital expenditures: 1390268.1231380338
Operating cash flow: 4438927.507447865
Depreciation & amortization: 3018867.9245283017
Net tangible assets: 22571996.027805362
Owner earnings: -863952.3336643497
Return on net tangible assets (%): -3.8275406951165865
Buffett classification: The Gruesome
Stock price: 0.1509433962264151
Shares outstanding: 461884437
Book value: 60536246.276067525
P/B ratio: 1.1516803547244094
Market cap (USD): 69718405.58490565
Debt to equity: 0.902230971128609
Current ratio: 0.9508142239946825
Quick ratio: 0.7897972748421401
COGS to revenue (%): 44.61849418898433
Free cash flow (dilution-adjusted): 3018867.9245283017
Buyback yield (%): 0
Inventory turnover: 1.8224974200206396
Receivables turnover: 1.4930215013202564
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -2.295918367346939
FCF margin (%): 7.6806467913087415
Revenue growth (%): 11.963847522358435
Rule of 40 score: 19.644494313667177
Financial ratios for SCANA.OL — quarterly report dated 2025-09-30
Total revenue: 38346693.38677355
Gross profit: 22384769.539078154
Operating income: 591182.3647294589
Net income: -80160.32064128257
Capital expenditures: 761523.0460921844
Operating cash flow: 1713426.8537074148
Depreciation & amortization: 3226452.905811623
Net tangible assets: 22905811.62324649
Owner earnings: 2384769.5390781565
Capex to operating income (%): 128.81355932203388
Buffett classification: The Gruesome
Stock price: 0.16032064128256512
Shares outstanding: 461884437
Book value: 61002004.008016035
P/B ratio: 1.213888139290407
Market cap (USD): 74049609.13827655
Debt to equity: 0.889454664914586
Current ratio: 0.9693597806805354
Quick ratio: 0.804225124979842
COGS to revenue (%): 41.62529396394042
Free cash flow (dilution-adjusted): 951903.8076152304
Buyback yield (%): 0
Inventory turnover: 1.5556640624999998
Receivables turnover: 1.5120505728960887
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.6133056133056134
FCF margin (%): 2.482362163574601
Revenue growth (%): -2.4377962595225693
Rule of 40 score: 0.04456590405203187
Financial ratios for SCANA.OL — quarterly report dated 2025-12-31
Total revenue: 44805970.149253726
Gross profit: 26437810.94527363
Operating income: 3930348.258706467
Net income: 1820895.5223880596
Capital expenditures: 726368.15920398
Operating cash flow: 13990049.75124378
Depreciation & amortization: 3074626.8656716417
Net tangible assets: 24597014.925373133
Owner earnings: 4169154.2288557217
Return on net tangible assets (%): 16.94983818770227
Capex to operating income (%): 18.481012658227847
Buffett classification: The Great
Stock price: 0.14143426294820718
P/E ratio: 8.968977641928191
Shares outstanding: 461884437
Book value: 62507462.68656716
P/B ratio: 1.045095771074727
Market cap (USD): 65326284.914342634
Debt to equity: 0.7502387774594078
Current ratio: 1.0298507462686566
Quick ratio: 0.8275080294728886
Effective tax rate (%): 32.08955223880597
COGS to revenue (%): 40.99489229402621
Free cash flow (dilution-adjusted): 13263681.5920398
Buyback yield (%): 0
Inventory turnover: 1.723622782446312
Receivables turnover: 1.8770320967069611
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.064204136228007
FCF margin (%): 29.602487230735065
Revenue growth (%): 16.844416537641017
Rule of 40 score: 46.44690376837608
Financial ratios for SCANA.OL — annual report dated 2025-12-31
Total revenue: 152835820.8955224
Gross profit: 85293532.33830845
Operating income: -1144278.606965174
Net income: -3611940.2985074623
Capital expenditures: 4676616.915422886
Operating cash flow: 17870646.766169153
Depreciation & amortization: 12039800.995024875
Net tangible assets: 24597014.925373133
Owner earnings: 3751243.781094526
Buffett classification: The Gruesome
Stock price: 0.14143426294820718
Shares outstanding: 461884437
Book value: 62507462.68656716
P/B ratio: 1.045095771074727
Market cap (USD): 65326284.914342634
Debt to equity: 0.7502387774594078
Current ratio: 1.0298507462686566
Quick ratio: 0.8275080294728886
Interest coverage ratio: -0.3267045454545454
COGS to revenue (%): 44.192708333333336
SG&A to revenue (%): 4.420572916666667
Free cash flow (dilution-adjusted): 13184079.60199005
Buyback yield (%): 0
Inventory turnover: 6.338001867413633
Receivables turnover: 6.402667778240934
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -1.1832493054841031
FCF margin (%): 8.626302083333332
Revenue growth (%): -0.05022506515044314
Rule of 40 score: 8.57607701818289
Financial ratios for SMCP.PA — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 8.34090909090909
Shares outstanding: 77826945
Market cap (USD): 649147473.0681818
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for SMCP.PA — annual report dated 2022-12-31
Total revenue: 1282765957.4468086
Gross profit: 818297872.3404256
Operating income: 111489361.70212767
Net income: 54574468.08510639
Capital expenditures: 48404255.319148935
Operating cash flow: 222340425.53191492
Depreciation & amortization: 166063829.78723404
Net tangible assets: -136808510.6382979
Owner earnings: 172234042.5531915
Return on net tangible assets (%): -125.89424572317263
Capex to operating income (%): 43.416030534351144
Buffett classification: The Good
Stock price: 6.904255319148937
P/E ratio: 9.845942944444444
Shares outstanding: 77826945
Book value: 1246914893.617021
P/B ratio: 0.4309332591502432
Market cap (USD): 537337098.9893618
Debt to equity: 0.6560873645593381
Current ratio: 1.0412941677309493
Quick ratio: 0.42060451255853554
Effective tax rate (%): 25.327510917030573
Interest coverage ratio: 4.657777777777778
COGS to revenue (%): 36.20832642229226
Free cash flow (dilution-adjusted): 167978723.40425533
Buyback yield (%): 1.4650654943309196
Inventory turnover: 1.4972565157750344
Receivables turnover: 19.17011128775835
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 5.483752812516352
FCF margin (%): 13.095040636921546
Rule of 40 score: 13.095040636921546
Financial ratios for SMCP.PA — annual report dated 2023-12-31
Total revenue: 1367222222.222222
Gross profit: 861333333.3333333
Operating income: 85000000
Net income: 12444444.444444444
Capital expenditures: 56333333.33333333
Operating cash flow: 234888888.8888889
Depreciation & amortization: 174333333.33333334
Net tangible assets: -135111111.1111111
Owner earnings: 130444444.44444446
Return on net tangible assets (%): -96.54605263157896
Capex to operating income (%): 66.27450980392156
Buffett classification: The Good
Stock price: 3.8
P/E ratio: 23.765013562500002
Shares outstanding: 77826945
Book value: 1311222222.2222223
P/B ratio: 0.22554711626133375
Market cap (USD): 295742391
Debt to equity: 0.6350309295822387
Current ratio: 1.0025591810620602
Quick ratio: 0.40157816165493704
Effective tax rate (%): 50.442477876106196
Interest coverage ratio: 2.8228782287822876
COGS to revenue (%): 37.001219016659896
Free cash flow (dilution-adjusted): 171333333.3333333
Buyback yield (%): 0.901685638521353
Inventory turnover: 1.6156848828956707
Receivables turnover: 18.042521994134898
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.0650406504065035
FCF margin (%): 12.531491263713937
Revenue growth (%): 6.5839184681446925
Rule of 40 score: 19.11540973185863
Financial ratios for SMCP.PA — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: -121354166.66666667
Buffett classification: The Gruesome
Stock price: 3.8229166666666665
Shares outstanding: 77826945
Book value: 1211562500.0000002
P/B ratio: 0.24557208163528496
Market cap (USD): 297525925.15625
Debt to equity: 0.6270312096982201
Current ratio: 0.9339581517000872
Quick ratio: 0.3668265039232781
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for SMCP.PA — annual report dated 2024-12-31
Total revenue: 1262187500
Gross profit: 795104166.6666667
Operating income: 53229166.66666667
Net income: -24583333.333333336
Capital expenditures: 42916666.66666667
Operating cash flow: 243645833.33333334
Depreciation & amortization: 170312500
Net tangible assets: -121354166.66666667
Owner earnings: 102812499.99999999
Capex to operating income (%): 80.62622309197653
Buffett classification: The Gruesome
Stock price: 3.8229166666666665
Shares outstanding: 77826945
Book value: 1211562500.0000002
P/B ratio: 0.24557208163528496
Market cap (USD): 297525925.15625
Debt to equity: 0.6270312096982201
Current ratio: 0.9339581517000872
Quick ratio: 0.3668265039232781
Interest coverage ratio: 1.6699346405228759
COGS to revenue (%): 37.00585953618883
Free cash flow (dilution-adjusted): 198125000
Buyback yield (%): 0.1400438185169404
Inventory turnover: 1.7232897770945428
Receivables turnover: 17.56086956521739
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.778230848692437
FCF margin (%): 15.696954691755385
Revenue growth (%): -7.682344575375854
Rule of 40 score: 8.014610116379531
Financial ratios for SMCP.PA — quarterly report dated 2025-06-30
Capital expenditures: 0
Net tangible assets: -125764705.88235295
Buffett classification: The Gruesome
Stock price: 5.03529411764706
Shares outstanding: 77826945
Book value: 1372588235.2941175
P/B ratio: 0.2855055494985858
Market cap (USD): 391881558.3529412
Debt to equity: 0.5170137996057257
Current ratio: 0.860161870503597
Quick ratio: 0.3450989208633093
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for SMJ.L — annual report dated 2021-07-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.015416666666666667
Shares outstanding: 38707931
Market cap (USD): 596747.2695833334
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for SMJ.L — annual report dated 2022-07-31
Total revenue: 17576829.268292684
Gross profit: 6784146.341463415
Operating income: 1542682.9268292685
Net income: 8074390.243902439
Capital expenditures: 404878.04878048785
Operating cash flow: -4931707.317073171
Depreciation & amortization: 486585.3658536586
Net tangible assets: 152043902.4390244
Owner earnings: 8156097.560975609
Return on net tangible assets (%): 5.364304276685168
Capex to operating income (%): 26.245059288537547
Buffett classification: The Good
Stock price: 0.01768292682926829
P/E ratio: 0.08477042735236369
Shares outstanding: 38707931
Book value: 152043902.4390244
P/B ratio: 0.004501788632134492
Market cap (USD): 684469.5115853657
Debt to equity: 0.0903301357117649
Current ratio: 3.4892537313432834
Quick ratio: 2.559850746268656
Effective tax rate (%): 19.177246093750004
Interest coverage ratio: 105.41666666666667
COGS to revenue (%): 61.40290015957815
SG&A to revenue (%): 29.82030111704711
Free cash flow (dilution-adjusted): -8037804.878048781
Buyback yield (%): 311.61750715937893
Retained earnings: 150814634.14634147
Inventory turnover: 0.7106150634334351
Receivables turnover: 11.604669887278583
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.9506989328122653
FCF margin (%): -45.7295497120655
Rule of 40 score: -45.7295497120655
Financial ratios for SMJ.L — annual report dated 2023-07-31
Total revenue: 16630769.23076923
Gross profit: 7756410.256410256
Operating income: 1837179.487179487
Net income: 256410.2564102564
Capital expenditures: 1123076.923076923
Operating cash flow: -4139743.5897435895
Depreciation & amortization: 570512.8205128205
Net tangible assets: 160855128.2051282
Owner earnings: -296153.8461538461
Return on net tangible assets (%): -0.18411215698151706
Capex to operating income (%): 61.130495464061404
Buffett classification: The Good
Stock price: 0.019615384615384614
P/E ratio: 2.9611567214999996
Shares outstanding: 38707931
Book value: 160855128.20512822
P/B ratio: 0.004720216027321925
Market cap (USD): 759270.9542307692
Debt to equity: 0.08531326962468218
Current ratio: 2.9188301999403166
Quick ratio: 1.5938525813190094
Effective tax rate (%): -90.47619047619048
Interest coverage ratio: 119.41666666666666
COGS to revenue (%): 53.36108541473944
SG&A to revenue (%): 35.59204440333025
Free cash flow (dilution-adjusted): -12737179.487179486
Buyback yield (%): 227.10719602147202
Retained earnings: 159562820.5128205
Inventory turnover: 0.38975225225225224
Receivables turnover: 20.821829855537718
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.065261185985831
FCF margin (%): -76.58803576934936
Revenue growth (%): -5.382427189129483
Rule of 40 score: -81.97046295847885
Financial ratios for SMJ.L — annual report dated 2024-07-31
Total revenue: 28230769.23076923
Gross profit: 5162820.512820513
Operating income: -566666.6666666666
Net income: 2144871.794871795
Capital expenditures: 1823076.923076923
Operating cash flow: -653846.1538461539
Depreciation & amortization: 583333.3333333333
Net tangible assets: 161939743.58974358
Owner earnings: 905128.205128205
Return on net tangible assets (%): 0.5589290096822971
Buffett classification: The Gruesome
Stock price: 0.015512820512820512
P/E ratio: 0.2799557472205618
Shares outstanding: 38707931
Book value: 161939743.58974358
P/B ratio: 0.0037079791082469736
Market cap (USD): 600469.186025641
Debt to equity: 0.04468265340859611
Current ratio: 4.881813701330705
Quick ratio: 3.037555446032528
Effective tax rate (%): 29.260042283298095
Interest coverage ratio: -27.625
COGS to revenue (%): 81.71207992733879
SG&A to revenue (%): 20.517711171662125
Free cash flow (dilution-adjusted): -4908974.358974359
Buyback yield (%): 192.58444618353417
Retained earnings: 160647435.8974359
Inventory turnover: 0.9616782469267771
Receivables turnover: 22.79503105590062
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.3241586177055144
FCF margin (%): -17.388737511353316
Revenue growth (%): 69.75023126734504
Rule of 40 score: 52.36149375599173
Financial ratios for SMJ.L — quarterly report dated 2025-01-31
Capital expenditures: 0
Net tangible assets: 156395000
Buffett classification: The Gruesome
Stock price: 0.015125
Shares outstanding: 38707931
Book value: 156395000
P/B ratio: 0.0037434537956776114
Market cap (USD): 585457.456375
Debt to equity: 0.090995556123917
Current ratio: 3.2660104819123097
Quick ratio: 1.9872171801099323
Buyback yield (%): 0
Retained earnings: 155135000
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for SMJ.L — annual report dated 2025-07-31
Total revenue: 30986666.666666668
Gross profit: 5773333.333333333
Operating income: -802666.6666666666
Net income: 6816000
Capital expenditures: 1053333.3333333333
Operating cash flow: 2638666.6666666665
Depreciation & amortization: 786666.6666666666
Net tangible assets: 174137333.33333334
Owner earnings: 6549333.333333334
Return on net tangible assets (%): 3.7610162094285733
Buffett classification: The Gruesome
Stock price: 0.015599999999999998
P/E ratio: 0.08859209559859155
Shares outstanding: 38707931
Book value: 174137333.33333334
P/B ratio: 0.003467629324747517
Market cap (USD): 603843.7235999999
Debt to equity: 0.0846228647121429
Current ratio: 2.9813793550898593
Quick ratio: 1.9168234607149808
Effective tax rate (%): 25.567850902737334
Interest coverage ratio: -50.166666666666664
COGS to revenue (%): 81.368330464716
SG&A to revenue (%): 21.222030981067125
Free cash flow (dilution-adjusted): -3042666.6666666665
Buyback yield (%): 144.84983986453855
Retained earnings: 172793333.33333334
Inventory turnover: 1.1524865919063871
Receivables turnover: 17.240356083086056
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.421208771217867
FCF margin (%): -9.819277108433734
Revenue growth (%): 9.762034514078126
Rule of 40 score: -0.057242594355608745
Financial ratios for SMJ.L — quarterly report dated 2025-07-31
Capital expenditures: 0
Net tangible assets: 174137333.33333334
Buffett classification: The Gruesome
Stock price: 0.015599999999999998
Shares outstanding: 38707931
Book value: 174137333.33333334
P/B ratio: 0.003467629324747517
Market cap (USD): 603843.7235999999
Debt to equity: 0.0846228647121429
Current ratio: 2.9813793550898593
Quick ratio: 1.9168234607149808
Buyback yield (%): 0
Retained earnings: 172793333.33333334
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for SURG — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 2.02
Shares outstanding: 25121895
Market cap (USD): 50746227.9
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for SURG — annual report dated 2022-12-31
Total revenue: 121544190
Gross profit: 13469408
Operating income: 626018
Net income: -553228
Capital expenditures: 11402
Operating cash flow: 793272
Depreciation & amortization: 988700
Net tangible assets: 156779
Owner earnings: 424070
Capex to operating income (%): 1.8213533796152825
Buffett classification: The Great
Stock price: 6.56
Shares outstanding: 25121895
Book value: 5118253
P/B ratio: 32.19841441992023
Market cap (USD): 164799631.2
Debt to equity: 1.5846938398707529
Current ratio: 1.1747234984292148
Quick ratio: 0.697984134204896
Interest coverage ratio: 0.31959260771901166
COGS to revenue (%): 88.91809801850668
SG&A to revenue (%): 9.80038371229427
Free cash flow (dilution-adjusted): 94690
Buyback yield (%): 0
Retained earnings: -35804106
Inventory turnover: 9.661402104477983
Receivables turnover: 13.167863892706302
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 5.939763046323885
FCF margin (%): 0.07790582174269292
Rule of 40 score: 0.07790582174269292
Financial ratios for SURG — annual report dated 2023-12-31
Total revenue: 137141832
Gross profit: 35642491
Operating income: 18865384
Net income: 20644612
Capital expenditures: 0
Operating cash flow: 10287345
Depreciation & amortization: 1107582
Net tangible assets: 23916544
Owner earnings: 21752194
Return on net tangible assets (%): 90.95040654703288
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 6.45
P/E ratio: 7.848838367608943
Shares outstanding: 25121895
Book value: 28403464
P/B ratio: 5.704804975548053
Market cap (USD): 162036222.75
Debt to equity: 0.19168433117876044
Current ratio: 2.626253084995219
Quick ratio: 1.9142056493468262
Effective tax rate (%): -12.323437513261977
Interest coverage ratio: 31.654656655061036
COGS to revenue (%): 74.0104893742414
SG&A to revenue (%): 11.45748731138432
Free cash flow (dilution-adjusted): 9439331
Buyback yield (%): 0
Retained earnings: -15186203
Inventory turnover: 11.219619339610023
Receivables turnover: 14.381372459987203
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 64.56267693415354
FCF margin (%): 6.882896970488188
Revenue growth (%): 12.832898059545256
Rule of 40 score: 19.715795030033444
Financial ratios for SURG — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 1.84
Shares outstanding: 25121895
Market cap (USD): 46224286.800000004
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for SURG — annual report dated 2024-12-31
Total revenue: 60881173
Gross profit: -14324199
Operating income: -41782351
Net income: -45729224
Capital expenditures: 518189
Operating cash flow: -21310603
Depreciation & amortization: 1292250
Net tangible assets: 10542957
Owner earnings: -44955163
Return on net tangible assets (%): -426.39994642869163
Buffett classification: The Gruesome
Stock price: 1.78
Shares outstanding: 25121895
Book value: 15261613
P/B ratio: 2.930029289826704
Market cap (USD): 44716973.1
Debt to equity: 0.3009086916304325
Current ratio: 2.9491531941045728
Quick ratio: 2.6551731535862175
Interest coverage ratio: -75.39218874052689
COGS to revenue (%): 123.5281258460641
SG&A to revenue (%): 43.187198446389985
Free cash flow (dilution-adjusted): -30190691
Buyback yield (%): 1.41325978971506
Retained earnings: -60915427
Inventory turnover: 42.21783407667716
Receivables turnover: 20.29231063569238
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -233.20561142172127
FCF margin (%): -49.58953566811204
Revenue growth (%): -55.607146184251064
Rule of 40 score: -105.1966818523631
Financial ratios for SURG — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 1.78
Shares outstanding: 25121895
Market cap (USD): 44716973.1
Buyback yield (%): 0.3283674851417884
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for SURG — quarterly report dated 2025-03-31
Total revenue: 10577429
Gross profit: -2942346
Operating income: -7579903
Net income: -7635084
Capital expenditures: 18590
Operating cash flow: -6963484
Depreciation & amortization: 310853
Net tangible assets: 3226444
Owner earnings: -7342821
Return on net tangible assets (%): -227.58247160031294
Buffett classification: The Gruesome
Stock price: 2.07
Shares outstanding: 25121895
Book value: 7781439
P/B ratio: 6.6828670956618685
Market cap (USD): 52002322.65
Debt to equity: 0.5296938008509737
Current ratio: 1.7160596524022016
Quick ratio: 1.4057311042802105
Interest coverage ratio: -63.46520253864059
COGS to revenue (%): 127.81721342681666
SG&A to revenue (%): 43.02969086344139
Free cash flow (dilution-adjusted): -7137193
Buyback yield (%): 0.005324762162330071
Retained earnings: -68550511
Inventory turnover: 7.589559130217558
Receivables turnover: 4.2532774884604825
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -76.381176776923
FCF margin (%): -67.47568809017767
Rule of 40 score: -67.47568809017767
Financial ratios for SURG — quarterly report dated 2025-06-30
Total revenue: 11518166
Gross profit: -2654666
Operating income: -6810509
Net income: -7082598
Capital expenditures: 0
Operating cash flow: -6118935
Depreciation & amortization: 292392
Net tangible assets: -4329640
Owner earnings: -6790206
Buffett classification: The Gruesome
Stock price: 3.11
Shares outstanding: 25121895
Book value: 61392
P/B ratio: 1272.6266199179047
Market cap (USD): 78129093.45
Debt to equity: 163.63068477977586
Current ratio: 1.114031846909051
Quick ratio: 0.8369923290656509
Interest coverage ratio: -24.383683128898056
COGS to revenue (%): 123.04764491152498
SG&A to revenue (%): 34.085513266608594
Free cash flow (dilution-adjusted): -6274054
Buyback yield (%): 0
Retained earnings: -75633109
Inventory turnover: 5.878850198915969
Receivables turnover: 4.296680025053036
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -104.56246718273574
FCF margin (%): -54.47094615583765
Revenue growth (%): 8.893815311830503
Rule of 40 score: -45.57713084400715
Financial ratios for SURG — quarterly report dated 2025-09-30
Total revenue: 18680317
Gross profit: -2596454
Operating income: -6950022
Net income: -7489068
Capital expenditures: 0
Operating cash flow: -4646386
Depreciation & amortization: 580512
Net tangible assets: -10652135
Owner earnings: -6908556
Buffett classification: The Gruesome
Stock price: 2.81
Shares outstanding: 25121895
Book value: -6424480
Market cap (USD): 70592524.95
Debt to equity: -1.9275555375687994
Current ratio: 0.5220751377471803
Quick ratio: 0.4135760991003418
Interest coverage ratio: -12.890534668009504
COGS to revenue (%): 113.89941080764314
SG&A to revenue (%): 22.286971896676057
Free cash flow (dilution-adjusted): -4862273
Buyback yield (%): 0
Retained earnings: -83122177
Inventory turnover: 11.0954226000291
Receivables turnover: 4.353146259969771
Capitalized R&D asset: 0
FCF margin (%): -26.02885700494269
Revenue growth (%): 62.181349009903144
Rule of 40 score: 36.15249200496045
Financial ratios for SURG — annual report dated 2025-12-31
Total revenue: 56962920
Gross profit: -10588891
Operating income: -30660012
Net income: -36068870
Capital expenditures: 18590
Operating cash flow: -21293152
Depreciation & amortization: 1111341
Net tangible assets: -16166828
Owner earnings: -34976119
Buffett classification: The Gruesome
Stock price: 1.67
Shares outstanding: 25121895
Book value: -15402819
Market cap (USD): 41953564.65
Debt to equity: -0.8817936508894898
Current ratio: 0.383709480184864
Quick ratio: 0.365041772959955
Interest coverage ratio: -15.299903439981836
COGS to revenue (%): 118.58909444951206
SG&A to revenue (%): 33.72570612602023
Free cash flow (dilution-adjusted): -23953467
Buyback yield (%): 0
Retained earnings: -96984297
Inventory turnover: 198.9333892864505
Receivables turnover: 14.081740113251335
Capitalized R&D asset: 0
FCF margin (%): -42.05098158591589
Revenue growth (%): -6.435902606541434
Rule of 40 score: -48.486884192457325
Financial ratios for SURG — quarterly report dated 2025-12-31
Total revenue: 16187007
Gross profit: -2395426
Operating income: -9319461
Net income: -13862120
Capital expenditures: 0
Operating cash flow: -3564347
Depreciation & amortization: 254790
Net tangible assets: -16166828
Owner earnings: -13607330
Buffett classification: The Gruesome
Stock price: 1.67
Shares outstanding: 25121895
Book value: -15402819
Market cap (USD): 41953564.65
Debt to equity: -0.8817936508894898
Current ratio: 0.383709480184864
Quick ratio: 0.365041772959955
Interest coverage ratio: -8.74214709044143
COGS to revenue (%): 114.79844915122356
SG&A to revenue (%): 41.59968547613527
Free cash flow (dilution-adjusted): -5679947
Buyback yield (%): 0
Retained earnings: -96984297
Inventory turnover: 54.72342374179109
Receivables turnover: 4.001572001319107
Capitalized R&D asset: 0
FCF margin (%): -35.089544348748355
Revenue growth (%): -13.347257436798316
Rule of 40 score: -48.43680178554667
Financial ratios for SYZ.DE — annual report dated 2021-12-31
Operating income: 7248863.636363637
Capital expenditures: 0
Depreciation & amortization: 121590.90909090909
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 6.636363636363636
Shares outstanding: 13500026
Market cap (USD): 89591081.63636363
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for SYZ.DE — annual report dated 2022-12-31
Total revenue: 75119148.93617022
Gross profit: 18212765.95744681
Operating income: 4034042.5531914895
Net income: -7852127.659574469
Capital expenditures: 672340.4255319149
Operating cash flow: 13364893.617021278
Depreciation & amortization: 17827659.574468087
Net tangible assets: 1668085.1063829788
Owner earnings: 9303191.489361705
Capex to operating income (%): 16.666666666666664
Buffett classification: The Great
Stock price: 5.340425531914893
Shares outstanding: 13500026
Book value: 47973404.255319156
P/B ratio: 1.5028302587870048
Market cap (USD): 72095883.53191489
Debt to equity: 0.685109213881805
Current ratio: 0.8178798125407843
Quick ratio: 0.8178798125407843
Interest coverage ratio: 5.511627906976744
COGS to revenue (%): 75.75482920750014
SG&A to revenue (%): 20.04050303064635
Free cash flow (dilution-adjusted): 12692553.191489363
Buyback yield (%): 0
Retained earnings: 7806382.978723405
Receivables turnover: 4.857064245425781
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 5.789578148617493
FCF margin (%): 16.89656149096471
Rule of 40 score: 16.89656149096471
Financial ratios for SYZ.DE — annual report dated 2023-12-31
Total revenue: 79713333.33333333
Gross profit: 15987777.777777778
Operating income: 3145555.5555555555
Net income: -3070000
Capital expenditures: 772222.2222222222
Operating cash flow: 7852222.222222222
Depreciation & amortization: 11088888.888888888
Net tangible assets: 891111.1111111111
Owner earnings: 7246666.666666666
Capex to operating income (%): 24.549629106322858
Buffett classification: The Great
Stock price: 3.644444444444444
Shares outstanding: 13500026
Book value: 44687777.77777778
P/B ratio: 1.1009742977199828
Market cap (USD): 49200094.75555555
Debt to equity: 0.6078719013401626
Current ratio: 0.8167938931297709
Quick ratio: 0.8167938931297709
Interest coverage ratio: 3.4149577804583835
COGS to revenue (%): 79.9434083242731
SG&A to revenue (%): 18.356053636642415
Free cash flow (dilution-adjusted): 7080000
Buyback yield (%): 0
Retained earnings: 8647777.777777778
Receivables turnover: 5.173204499567349
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.9067526344980585
FCF margin (%): 8.881826545120013
Revenue growth (%): 6.115863214939841
Rule of 40 score: 14.997689760059854
Financial ratios for SYZ.DE — quarterly report dated 2024-09-30
Capital expenditures: 215555.55555555556
Depreciation & amortization: 0
Buffett classification: The Gruesome
Stock price: 3.466666666666667
Shares outstanding: 13500026
Market cap (USD): 46800090.13333333
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for SYZ.DE — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 2.8333333333333335
Shares outstanding: 13500026
Market cap (USD): 38250073.66666667
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for SYZ.DE — annual report dated 2024-12-31
Total revenue: 72321875
Gross profit: 16270833.333333334
Operating income: 4690625
Net income: -13707291.666666668
Capital expenditures: 7291.666666666667
Operating cash flow: 10035416.666666668
Depreciation & amortization: 21870833.333333336
Net tangible assets: 4410416.666666667
Owner earnings: 8156250.000000001
Capex to operating income (%): 0.1554519209415945
Buffett classification: The Great
Stock price: 2.8333333333333335
Shares outstanding: 13500026
Book value: 28785416.66666667
P/B ratio: 1.3288004168777592
Market cap (USD): 38250073.66666667
Debt to equity: 0.6823116450749076
Current ratio: 0.9549279818740896
Quick ratio: 0.9549279818740896
Interest coverage ratio: 5.458181818181818
COGS to revenue (%): 77.50219648849905
SG&A to revenue (%): 17.28096328623486
Free cash flow (dilution-adjusted): 9336458.333333334
Buyback yield (%): 0
Retained earnings: 14613541.666666668
Receivables turnover: 5.192506170069554
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 10.471849491872282
FCF margin (%): 12.909591093059097
Revenue growth (%): -9.272549552563346
Rule of 40 score: 3.6370415404957512
Financial ratios for SYZ.DE — quarterly report dated 2025-03-31
Total revenue: 16228260.869565217
Gross profit: 3282608.695652174
Operating income: 314130.4347826087
Net income: 151086.95652173914
Capital expenditures: 232608.6956521739
Operating cash flow: -3677173.913043478
Depreciation & amortization: 996739.1304347826
Net tangible assets: 4690217.391304348
Owner earnings: 915217.3913043479
Return on net tangible assets (%): 19.513325608342992
Capex to operating income (%): 74.04844290657438
Buffett classification: The Good
Stock price: 2.8260869565217392
P/E ratio: 63.12961798561151
Shares outstanding: 13500026
Book value: 29845652.17391304
P/B ratio: 1.278318435428655
Market cap (USD): 38152247.39130435
Debt to equity: 0.6917109767645132
Current ratio: 0.9348192229957333
Quick ratio: 0.9348192229957333
Effective tax rate (%): 26.737967914438503
Interest coverage ratio: 1.888888888888889
COGS to revenue (%): 79.7722705961152
SG&A to revenue (%): 21.01808439383791
Free cash flow (dilution-adjusted): -3909782.608695652
Buyback yield (%): 0
Retained earnings: 15400000
Receivables turnover: 1.5762246621621623
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.6909742976688584
FCF margin (%): -24.092431346282652
Rule of 40 score: -24.092431346282652
Financial ratios for SYZ.DE — quarterly report dated 2025-06-30
Total revenue: 17034117.647058822
Gross profit: 3917647.0588235296
Operating income: 250588.23529411765
Net income: 96470.58823529413
Capital expenditures: 116470.58823529413
Operating cash flow: 2208235.294117647
Depreciation & amortization: 1064705.8823529412
Net tangible assets: 5167058.823529412
Owner earnings: 1044705.8823529413
Return on net tangible assets (%): 20.21857923497268
Capex to operating income (%): 46.47887323943662
Buffett classification: The Good
Stock price: 3
P/E ratio: 163.59864143809082
Shares outstanding: 13500026
Book value: 32257647.058823533
P/B ratio: 1.2555186658886173
Market cap (USD): 40500078
Debt to equity: 0.58856996972902
Current ratio: 0.9472036225251699
Quick ratio: 0.9472036225251699
Effective tax rate (%): 36.22047244094488
Interest coverage ratio: 1.58955223880597
COGS to revenue (%): 77.00117411423442
SG&A to revenue (%): 23.516817459769324
Free cash flow (dilution-adjusted): 2091764.705882353
Buyback yield (%): 0
Retained earnings: 16764705.88235294
Receivables turnover: 1.6677032941718495
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.5209862048723217
FCF margin (%): 12.279853581048418
Revenue growth (%): 4.965761790315586
Rule of 40 score: 17.245615371364003
Financial ratios for SYZ.DE — quarterly report dated 2025-09-30
Total revenue: 16909411.76470588
Gross profit: 3087058.823529412
Operating income: -582352.9411764706
Net income: -515294.11764705885
Capital expenditures: 149411.76470588235
Operating cash flow: -2904705.882352941
Depreciation & amortization: 1060000
Net tangible assets: 4636470.588235294
Owner earnings: 395294.11764705885
Buffett classification: The Gruesome
Stock price: 2.2941176470588234
Shares outstanding: 13500026
Book value: 31456470.58823529
P/B ratio: 0.9845557147131424
Market cap (USD): 30970647.88235294
Debt to equity: 0.7684942778068669
Current ratio: 0.9438329692488657
Quick ratio: 0.9438329692488657
Interest coverage ratio: -3.5611510791366907
COGS to revenue (%): 81.74354692826829
SG&A to revenue (%): 18.590412579141447
Free cash flow (dilution-adjusted): -3054117.6470588236
Buyback yield (%): 0
Retained earnings: 16245882.352941178
Receivables turnover: 1.1036627505183136
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -1.2577178138577636
FCF margin (%): -18.061643359076047
Revenue growth (%): -0.7320947579252686
Rule of 40 score: -18.793738117001315
Financial ratios for SYZ.DE — annual report dated 2025-12-31
Total revenue: 66875294.11764706
Gross profit: 9952941.176470589
Operating income: -1818823.5294117648
Net income: -10927058.823529413
Capital expenditures: 30588.235294117647
Operating cash flow: 6195294.117647059
Depreciation & amortization: 13328235.294117648
Net tangible assets: 3008235.294117647
Owner earnings: 2370588.2352941176
Buffett classification: The Gruesome
Stock price: 1.811764705882353
Shares outstanding: 13500026
Book value: 20869411.76470588
P/B ratio: 1.1719961688933989
Market cap (USD): 24458870.635294117
Debt to equity: 0.8148711877783416
Current ratio: 0.8983680454109103
Quick ratio: 0.8983680454109103
Interest coverage ratio: -2.5939597315436242
COGS to revenue (%): 85.11716276124129
SG&A to revenue (%): 18.682710576314125
Free cash flow (dilution-adjusted): 5582352.94117647
Buyback yield (%): 0
Retained earnings: 6940000
Receivables turnover: 5.077623939258597
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -5.246546984762617
FCF margin (%): 8.347406938287241
Revenue growth (%): -7.531028312461396
Rule of 40 score: 0.8163786258258448
Financial ratios for SYZ.DE — quarterly report dated 2025-12-31
Total revenue: 15367058.823529413
Gross profit: -604705.8823529412
Operating income: -1827058.8235294118
Net income: -10668235.294117648
Capital expenditures: 95294.11764705883
Operating cash flow: 10871764.705882354
Depreciation & amortization: 10124705.88235294
Net tangible assets: 3008235.294117647
Owner earnings: -638823.5294117662
Return on net tangible assets (%): -21.235823230348114
Buffett classification: The Gruesome
Stock price: 1.811764705882353
Shares outstanding: 13500026
Book value: 20869411.76470588
P/B ratio: 1.1719961688933989
Market cap (USD): 24458870.635294117
Debt to equity: 0.8148711877783416
Current ratio: 0.8983680454109103
Quick ratio: 0.8983680454109103
Interest coverage ratio: -9.135294117647058
COGS to revenue (%): 103.935078854693
SG&A to revenue (%): 10.756392589190016
Free cash flow (dilution-adjusted): 10776470.588235294
Buyback yield (%): 0
Retained earnings: 6940000
Receivables turnover: 1.166770879857079
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -5.270302372145112
FCF margin (%): 70.12708620425661
Revenue growth (%): -9.121269046128146
Rule of 40 score: 61.005817158128465
Financial ratios for THEON.AS — annual report dated 2024-12-31
Total revenue: 367045853.125
Gross profit: 113760359.375
Operating income: 90137019.79166667
Net income: 70248953.125
Capital expenditures: 2625727.0833333335
Operating cash flow: -27204288.541666668
Depreciation & amortization: 2614751.041666667
Net tangible assets: 210676954.1666667
Owner earnings: 70237977.08333334
Return on net tangible assets (%): 33.33918385195945
Capex to operating income (%): 2.9130396028204237
Buffett classification: The Great
Stock price: 12.84375
P/E ratio: 14.191743841378418
Shares outstanding: 77621812
Book value: 246044396.87500003
P/B ratio: 4.051931929917068
Market cap (USD): 996955147.875
Debt to equity: 0.32215582400332465
Current ratio: 3.082152113343713
Quick ratio: 2.3764806293589382
Effective tax rate (%): 22.213858190612935
Interest coverage ratio: 19.872937412728742
COGS to revenue (%): 69.00649921353065
R&D to revenue (%): 1.3620573444532087
SG&A to revenue (%): 5.1344748681618375
Free cash flow (dilution-adjusted): -38378445.833333336
Buyback yield (%): 0.8126992364972345
Inventory turnover: 3.203734114524533
Receivables turnover: 2.7976518777511528
Capitalized R&D asset: 7786195.000472814
ROCI (R&D-adjusted, %): 30.119728115389595
Rosenberg metric: 11.460276827797427
FCF margin (%): -10.456035807674223
Revenue growth (%): 51.031858927997774
Rule of 40 score: 40.57582312032355
Financial ratios for THEON.AS — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 210676954.1666667
Buffett classification: The Gruesome
Stock price: 12.84375
Shares outstanding: 77621812
Book value: 246044396.87500003
P/B ratio: 4.051931929917068
Market cap (USD): 996955147.875
Debt to equity: 0.32215582400332465
Current ratio: 3.082152113343713
Quick ratio: 2.3764806293589382
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for THEON.AS — quarterly report dated 2025-06-30
Capital expenditures: 0
Net tangible assets: 246348967.05882353
Buffett classification: The Gruesome
Stock price: 35.49411764705883
Shares outstanding: 77621812
Book value: 290159860
P/B ratio: 9.495171823924519
Market cap (USD): 2755117727.1058826
Debt to equity: 0.3796623817278233
Current ratio: 3.246868647786962
Quick ratio: 2.387188308053067
Buyback yield (%): 0
Retained earnings: 189949312.94117647
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for UIS — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 20.57
Shares outstanding: 72905170
Market cap (USD): 1499659346.9
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for UIS — annual report dated 2022-12-31
Total revenue: 1979900000
Gross profit: 529600000
Operating income: 19800000
Net income: -104900000
Capital expenditures: 31000000
Operating cash flow: 12700000
Depreciation & amortization: 183500000
Net tangible assets: -519300000
Owner earnings: 47600000
Capex to operating income (%): 156.56565656565658
Buffett classification: The Gruesome
Stock price: 5.11
Shares outstanding: 72905170
Book value: 21800000
P/B ratio: 17.089239389908258
Market cap (USD): 372545418.70000005
Debt to equity: 26.091743119266056
Current ratio: 1.4302843966179861
Quick ratio: 1.407378939277479
Interest coverage ratio: 0.6111111111111112
COGS to revenue (%): 73.25117430173242
R&D to revenue (%): 1.2222839537350372
SG&A to revenue (%): 22.89004495176524
Free cash flow (dilution-adjusted): -84600000
Buyback yield (%): 0
Retained earnings: -1515000000
Inventory turnover: 97.33557046979865
Receivables turnover: 4.589476124246639
Capitalized R&D asset: 24200000
ROCI (R&D-adjusted, %): 2.4965839875865585
FCF margin (%): -4.272943077933229
Rule of 40 score: -4.272943077933229
Financial ratios for UIS — annual report dated 2023-12-31
Total revenue: 2015400000
Gross profit: 551300000
Operating income: 76900000
Net income: -427100000
Capital expenditures: 32700000
Operating cash flow: 74200000
Depreciation & amortization: 138800000
Net tangible assets: -648100000
Owner earnings: -321000000
Capex to operating income (%): 42.52275682704811
Buffett classification: The Good
Stock price: 5.62
Shares outstanding: 72905170
Book value: -138400000
Market cap (USD): 409727055.40000004
Debt to equity: -3.966040462427746
Current ratio: 1.491780611461054
Quick ratio: 1.4682746965739746
Interest coverage ratio: 2.4967532467532467
COGS to revenue (%): 72.64562865932321
R&D to revenue (%): 1.1957923985313088
SG&A to revenue (%): 22.342959214051803
Free cash flow (dilution-adjusted): -21700000
Buyback yield (%): 0
Retained earnings: -1945700000
Inventory turnover: 95.69281045751634
Receivables turnover: 4.323037323037323
Capitalized R&D asset: 40314000
ROCI (R&D-adjusted, %): 6.266542861234088
Rosenberg metric: 0.8966942148760331
FCF margin (%): -1.0767093380966557
Revenue growth (%): 1.7930198494873477
Rule of 40 score: 0.716310511390692
Financial ratios for UIS — quarterly report dated 2024-09-30
Capital expenditures: 6800000
Buffett classification: The Gruesome
Stock price: 5.68
Shares outstanding: 72905170
Market cap (USD): 414101365.59999996
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for UIS — quarterly report dated 2024-12-31
Capital expenditures: 5000000
Buffett classification: The Gruesome
Stock price: 6.33
Shares outstanding: 72905170
Market cap (USD): 461489726.1
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for UIS — annual report dated 2024-12-31
Total revenue: 2008400000
Gross profit: 585900000
Operating income: 136500000
Net income: -193200000
Capital expenditures: 32300000
Operating cash flow: 135100000
Depreciation & amortization: 106400000
Net tangible assets: -731800000
Owner earnings: -119100000
Capex to operating income (%): 23.66300366300366
Buffett classification: The Great
Stock price: 6.33
Shares outstanding: 72905170
Book value: -269300000
Market cap (USD): 461489726.1
Debt to equity: -1.994430003713331
Current ratio: 1.5593949044585986
Quick ratio: 1.53328025477707
Interest coverage ratio: 4.278996865203761
COGS to revenue (%): 70.82752439753037
R&D to revenue (%): 1.254730133439554
SG&A to revenue (%): 21.121290579565823
Free cash flow (dilution-adjusted): 34100000
Buyback yield (%): 0
Retained earnings: -2139100000
Inventory turnover: 86.73780487804878
Receivables turnover: 4.156456953642384
Capitalized R&D asset: 49333000
ROCI (R&D-adjusted, %): 10.60579005019198
Rosenberg metric: 1.4356846473029046
FCF margin (%): 1.6978689504082853
Revenue growth (%): -0.34732559293440507
Rule of 40 score: 1.3505433574738803
Financial ratios for UIS — quarterly report dated 2025-03-31
Total revenue: 432100000
Gross profit: 107500000
Operating income: -16400000
Net income: -29500000
Capital expenditures: 20100000
Operating cash flow: 33300000
Depreciation & amortization: 22600000
Net tangible assets: -715200000
Owner earnings: -27000000
Buffett classification: The Gruesome
Stock price: 4.59
Shares outstanding: 72905170
Book value: -254100000
Market cap (USD): 334634730.3
Debt to equity: -2.07556080283353
Current ratio: 1.6728297235428773
Quick ratio: 1.6347948582496918
Interest coverage ratio: -2
COGS to revenue (%): 75.12149965285813
R&D to revenue (%): 1.2959962971534367
SG&A to revenue (%): 27.37792177736635
Free cash flow (dilution-adjusted): 6400000
Buyback yield (%): 0
Retained earnings: -2168600000
Inventory turnover: 15.027777777777779
Receivables turnover: 0.9740757439134355
Capitalized R&D asset: 5600000
ROCI (R&D-adjusted, %): -0.99113197704747
FCF margin (%): 1.4811386253182135
Rule of 40 score: 1.4811386253182135
Financial ratios for UIS — quarterly report dated 2025-06-30
Total revenue: 483300000
Gross profit: 130000000
Operating income: 8700000
Net income: -20000000
Capital expenditures: 20300000
Operating cash flow: -316200000
Depreciation & amortization: 26000000
Net tangible assets: -666900000
Owner earnings: -14300000
Capex to operating income (%): 233.33333333333334
Buffett classification: The Gruesome
Stock price: 4.53
Shares outstanding: 72905170
Book value: -206900000
Market cap (USD): 330260420.1
Debt to equity: -3.545190913484775
Current ratio: 1.6593182660244534
Quick ratio: 1.6078177102630604
Interest coverage ratio: 1.0609756097560976
COGS to revenue (%): 73.10159321332506
R&D to revenue (%): 1.2621560107593628
SG&A to revenue (%): 23.83612662942272
Free cash flow (dilution-adjusted): -339400000
Buyback yield (%): 0
Retained earnings: -2188700000
Inventory turnover: 12.70863309352518
Receivables turnover: 1.028735632183908
Capitalized R&D asset: 9852000
ROCI (R&D-adjusted, %): 0.8605362798937671
Rosenberg metric: 4.017857142857143
FCF margin (%): -70.2255327953652
Revenue growth (%): 11.849109002545708
Rule of 40 score: -58.37642379281949
Financial ratios for UIS — quarterly report dated 2025-09-30
Total revenue: 460200000
Gross profit: 117200000
Operating income: 21500000
Net income: -308900000
Capital expenditures: 5600000
Operating cash flow: 38000000
Depreciation & amortization: 21900000
Net tangible assets: -692100000
Owner earnings: -292600000
Capex to operating income (%): 26.046511627906977
Buffett classification: The Good
Stock price: 3.9
Shares outstanding: 72905170
Book value: -285100000
Market cap (USD): 284330163
Debt to equity: -2.6983514556296035
Current ratio: 1.5336640680368534
Quick ratio: 1.501417434443657
Interest coverage ratio: 1.1813186813186813
COGS to revenue (%): 74.53281182094742
R&D to revenue (%): 1.0430247718383312
SG&A to revenue (%): 19.752281616688396
Free cash flow (dilution-adjusted): 17400000
Buyback yield (%): 0
Retained earnings: -2497600000
Inventory turnover: 18.846153846153847
Receivables turnover: 1.0967588179218304
Capitalized R&D asset: 10735000
ROCI (R&D-adjusted, %): 1.7477008910753822
Rosenberg metric: -2.098360655737705
FCF margin (%): 3.780964797913951
Revenue growth (%): -4.779639975170701
Rule of 40 score: -0.9986751772567501